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Abstract
Background: Waiting times for elective care have been considered a serious problem in many health care systems.
A topic of particular concern has been how administrative boundaries act as barriers to efficient patient flows. In
Norway, a policy combining patient’s choice of hospital and removal of restriction on referrals was introduced in
2001, thereby creating a nationwide competitive referral system for elective hospital treatment. The article aims to
analyse if patient choice and an increased opportunity for geographical mobility has reduced waiting times for
individual elective patients.
Methods: A survey conducted among Norwegian somatic patients in 2004 gave information about whether the
choice of hospital was made by the individual patient or by others. Survey data was then merged with
administrative data on which hospital that actually performed the treatment. The administrative data also gave
individual waiting time for hospital admission. Demographics, socio-economic position, and medical need were
controlled for to determine the effect of choice and mobility upon waiting time. Several statistical models,
including one with instrument variables for choice and mobility, were run.
Results: Patients who had neither chosen hospital individually nor bypassed the local hospital for other reasons
faced the longest waiting times. Next were patients who individually had chosen the local hospital, followed by
patients who had not made an individual choice, but had bypassed the local hospital for other reasons. Patients
who had made a choice to bypass the local hospitals waited on average 11 weeks less than the first group.
Conclusion: The analysis indicates that a policy combining increased opportunity for hospital choice with the
removal of rules restricting referrals can reduce waiting times for individual elective patients. Results were robust
over different model specifications.
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1. Background
Waiting times for elective surgery have been, and still
are, an important health policy concern in many
advanced industrial countries. Policymakers have over
the last twenty years increasingly addressed the question
of how to tackle the problem [1]. Both supply and
demand policies have been introduced in an attempt to
meet the challenge posed by excessive waiting times [2].
Initiatives on the demand side include: prioritizing
patients according to need and providing treatment only
to medium and high risk patients; encouraging private
health insurance cover to reduce the demand for public
treatment and increase the demand for private treat-
ment; and allowing patients greater opportunities for
choosing their hospital [1]. The latter type of reform has
been introduced in Sweden, Norway, Denmark, The
Netherlands, England, Germany, France, and Belgium
[3-6]. In Norway, the reform, which came into effect in
2001, also meant a removal of rules restricting referrals
to providers within a single district, thereby creating a
competitive referral system for elective care [7,8].
There has, in periods, been a lot of political interest in
the potential benefits of patient choice. Claims about
choice being a vehicle for improving accessibility have
also been made on theoretical grounds [9]. Despite this
optimism, recent reviews of the patient choice literature
in the UK, Europe and USA, conclude that there is still
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little evidence of greater choice having such effects
[4,5,10]. A hospital-level analysis of the effect of choice
on waiting times in the UK concluded that more choice
was significantly associated with shorter waiting times.
The quantitative effect, however, was modest. The same
study also provided evidence indicating that more
choice can have the adverse effect of boosting waiting
times [11]. At the patient level, an evaluation of the
London Patient Choice Project showed a reduction in
waiting times for all patients, including those outside
the project [6].
Patient mobility (i.e. geographical movement by
patients across administrative boundaries to other hos-
pitals) was first described in a study of waiting times
for elective surgery in Canada [12]. The study also
included a taxonomy of causes of mobility. The causes
identified were: patients’ choice of hospital, general
practitioner (GP) induced mobility, and structurally
caused mobility.
Here, the conceptual separation of patient choice and
patient mobility is used as a framework for evaluating
patient choice reforms. We first distinguished between a
dimension that describe the decision (if the choice is
made by the individual patient or by others, for example
the GP) and a dimension that describe the result of this
decision (if the result imply geographical mobility or
not). Secondly, we combined the two dimensions to
form a typology with four different alternatives: one
which implied neither choice nor mobility (i.e. not
bypassing the local hospital); one with individual choice
but without mobility; one without individual choice but
with mobility; and one with both individual choice and
mobility. The non-choice and mobility alternative,
would be due to either a GP’s decision or influenced by
structural features of the health care system (e.g. hospi-
tal specialization).
Prior to the reform Norwegian policymakers blamed
long waiting times for elective care both to the lack of
patient choice and administrative borders creating bar-
riers for patients moving to hospital facilities in other
counties. Consequently it was believed that shorter wait-
ing times could be obtained through a policy combining
an individual right for patients to choose hospital with
the removal of county border barriers [13]. The article
aims to shed light on whether the introduction of patient
choice and the increased opportunity for geographical
mobility has contributed to reduce waiting times for elec-
tive patients at patient level. Whether changes in waiting
time at individual level affect the overall waiting time of
the system is another question and a question that will
not be discuss. It will, however, to some extent depend
on the utilization of the general capacity of the system. If
this increases due to increased patient mobility, the over-
all waiting times should be reduced [6].
2. Institutional setting
In Norway, long waiting times became an important
part of the perception of a general “health care crisis”
during the 1980s and 1990s. Prolonged waiting times
were not a new phenomenon, but it was not until the
1985 parliamentary election campaign that it was con-
sidered politically unacceptable [14]. Independent
reports at the time estimated that more than 100 000
patients were waiting for in-patient care, and that the
number had been increasing since the beginning of the
1970s [15].
Figure 1 depicts the development in waiting times for
elective in-patient and outpatient treatment between 1998
and 2006 across the five Norwegian health care regions.
The figure confirms the description of long average wait-
ing times for elective patients in the 90s. In the period
from 1998 to 2000, the average waiting time was close to
250 days. From 2000 the average waiting time dropped
markedly. From 2005 it has been stable at about 70 days.
In the 1980s and early 1990s the favoured answer was
to increase the capacity of hospitals without increasing
total health care expenditure. Thus, efficiency was to be
improved through organizational and other non-finan-
cial measures [14]. In 1997, activity-based financing
(ABF) of hospitals was introduced. Recent research has
shown that the introduction of ABF and the subsequent
expansion of hospital budgets were both important fac-
tors in reducing waiting times for elective treatment
[16]. Another, often cited cause of reduced waiting
times was the “cleaning up” of hospital waiting lists
from 2000 to 2002 [17].
In the latter part of the 1990s, a new initiative was taken,
this time related to the demand side. The Patients’ Rights
Act, which came into effect on January 1st 2001, implied
that patients were given an explicit right to decide at
which hospital to receive elective treatment and the
removal of geographical limitations on choice. All previous
 
Source: NPR/VENTSYS
Figure 1 Average waiting times in days for somatic treatment
1998-2010.
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geographical barriers to mobility were removed so patients
got the opportunity to choose a hospital anywhere in the
country. The right to choose hospital was extended in
2004 to also include private hospitals under contract with
a Regional Health Authority.
3. Methods
Research design
The major difficulty within empirical studies on hospital
choice has been how to identify patient choice from
administrative data. Moreover, administrative data nor-
mally lack pre-hospitalization information about
patients. In an attempt to overcome this problem, a
cross-sectional survey covering questions related to per-
sonal hospital choices was carried out among Norwegian
elective patients in 2004 (questionnaire included as addi-
tional file 1).
To allow for generalization, the study sample was
drawn using a two-stage procedure. In the first stage, 20
hospitals were randomly selected among all Norwegian
hospitals in order to assure representativeness regarding
both hospital size and geographical location. In the sec-
ond stage, 4000 elective patients were drawn from the
registers of the 20 hospitals. The Patient Choice Pilot
Project evaluation (1994-1996) found both patient
choice and mobility to be rare phenomena [18]. Conse-
quently, it was decided to increase the proportion of
mobile patients (i.e. patients not treated locally) in the
study. The total sample contained 3000 mobile patients
and 1000 that had been treated at the local hospital.
Due to the study design, the data used in the following
analyses has been weighted to reflect the universe con-
sisting of all Norwegian elective patients.
The participants received a self-administered question-
naire in the mail during the summer and autumn of
2004 [19]. The questions asked were all related to a par-
ticular treatment episode, which took place between the
autumn of 2003 and spring of 2004. 664 questionnaires
were returned unopened, and were removed from the
sample. After one reminder, completed questionnaires
were obtained from 1678 patients, giving a response rate
of close to 50%. The questionnaire information was then
combined with administrative data about the same treat-
ment episode from the Norwegian Patient Register
(NPR).
Participants were asked whether they had chosen the
hospital where they had been treated or not. NPR pro-
vided information about the participant’s home munici-
pality and place of treatment (hospital). This made it
possible to determine if the patient had been treated
locally (non-mobile) or had bypassed the local hospital
(mobile). The survey data and the register data were
then combined to operationalise the typology of choice
and mobility presented in the introduction. Thus,
individual patients were categorised into four groups:
Group 1-Patients that had neither chosen nor bypassed
the local hospital; Group 2-Patients that had chosen not
to bypass the local hospital; Group 3-Patients that had
not chosen but still had moved; Group 4-patients that
had both chosen and moved.
The dependent variable
To measure the actual waiting time for each patient,
information provided by NPR was used. The waiting
time variable was constructed using the difference
between the date of hospital admission for the particular
treatment episode and the date the hospital received the
letter of referral. The latter date was assumed to be a
good proxy for the referral date. Private hospitals were,
at the time of the survey, not obliged to report the refer-
ral date to the NPR. 78 privately treated participants
were therefore excluded. We further suspect that some
extreme waiting times were due to measurement errors
and therefore set maximum waiting time to four and a
half years (1650 days). This excluded 4.5 percent of the
sample.
Explanatory variables
The analysis of choice and mobility was based upon the
assumptions that all patients had the wish to be treated
without delay, but that there were variations in their
opportunities or capacity to pursue this aim. Moreover,
it was assumed that it was the individual patient’s
expectation of shorter waiting times that was the prime
motivator for the decision to choose hospital. Differ-
ences in motivation can be caused by a particular illness
(e.g. dementia) or other idiosyncratic factors. Further-
more it was assumed that those who were mobile had
better opportunities to travel than those who did not,
due to for instance illness, duties at home, lack of time
etc. According to this it seems fair to assume that group
4 patients will have shorter waiting times than group 1
patients who had neither chosen nor moved. The
remaining groups, which are less clear cut, will probably
face waiting times somewhere between group 1 and 4.
Patients in the second group had made a deliberate
decision to be treated locally, perhaps because cost of
waiting (e.g. travel expenses, being away from home) for
the local hospital had been perceived to be less than
costs associated with travelling elsewhere. Patients in
the third group had not chosen the hospital but have
still received treatment elsewhere. Thus, someone, like
the referring doctor, must have been acting on their
behalf. If this was the case, it is the referring physician
who has possessed information both about the patient’
preferences and differences in waiting times, and has
been willing to use this in a beneficial way for the
patient.
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Other variables were included as controls [20-23]. We
included five socioeconomic variables: gender, age, perso-
nal income, educational level and participant’s area of
residence (for details, see the technical appendix). The
patient’s need for health care services was measured by
self-assessed health, GP-utilization and hospital utiliza-
tion. Two variables related to the particular treatment
episode were also included. The condition treated was
based on the ICD-10 chapter classification. Chapter 21
(factors influencing health status and contact with
health services) is the reference category. In addition, a
dummy for type of treatment was created to distinguish
between patients who had been treated for a medical
condition (non-surgical) and those treated for a surgical
condition. Finally, a dummy variable of the year of treat-
ment was included in the model. The last three variable
vectors were used to construct fixed-effect regression
models. The fixed effect models means that we utilize
variations within these groups to estimate the effects of
patient choice and mobility.
Statistics and estimation method
Since it is the wish to be treated without delay, an
omitted variable, that drives choice and mobility, it can
be argued that variables describing choice and mobility
are endogenous and need to be instrumented [24]. We
therefore supplemented the OLS models with fixed
effects with a two stage least square model (2SLS)
where instruments for choice and mobility were
included. Reliable instruments for the four variables that
described choice and mobility were however difficult to
find and we were forced to instrument a dummy vari-
able that took the value of 1 if the patient either had
chosen or was mobile, otherwise it took the value of 0
(no choice, no mobility). Age, gender, personal income,
educational level, self-assessed health, type of treatment
(surgical vs. non-surgical) and distance to local hospitals
were used as instruments. The validity of the instru-
ments was tested by the method recommended by Dra-
nove and Wehner [25]. We correlated the residual from
the first stage regression and our instruments and found
no significant correlation for personal income, educa-
tional level and type of treatment. As a consequence,
these variables were excluded from the second stage
regression. Overidentification was tested by a Basmann
test and rejected (F = 2.61, p = 0.05) [26]. The depen-
dent variable was skewed and therefore log-transformed
in two of the specifications. Statistical analyses were per-
formed by SAS, version 9.2. Final regressions were made
by “proc reg” and “proc syslin”.
The project, including the survey, was approved by the
local regional medical ethics committee (REK Sør) in
December 2005 (reference S- 05344).
4. Results
Waiting times for elective hospital treatment were, as
seen in Figure 1, still substantial. Table 1 shows the
average waiting times of the participants in the study
according to their condition described by main diag-
noses of the ICD-10 system.
Patients waited on average 278.8 days from the time of
referral to hospital admission. The higher waiting time
in table 1 compared to Figure 1, reflects both differences
in data source and registration practice. Figure 1 is
based on hospital reports on waiting time from referral
to starting point of a treatment period, and is taken
from the National system for waiting time-VENTSYS.
Table 1, on the other hand, reflects waiting time from
referral to a specific treatment (that can be within a
treatment period), and is based on information from
NPR. There were large differences in waiting times for
different conditions. Patients treated for conditions asso-
ciated with pregnancy, childbirth and the puerperium
(Chapter 15) waited about 130 days, while those treated
for congenial malformations, deformations, and chromo-
some abnormalities (Chapter 17) waited an average of
587 days.
Table 2 contains weighted descriptive information on
survey participants. On average, the participants were
approximately 46 years old at the time of the study and
had about four years of formal tertiary education. Sixty-
two per cent reported good or very good general health
prior to the treatment episode.
Table 3 shows the results from the regression ana-
lyses. In Model 1 (non-logged dependent variable)
socio-demographic variables and patients’ need for hos-
pital services were included on the right hand side in
addition to fixed effects for year, medical conditions
(ICD-10) and type of treatment. Women had on average
24 days longer waiting time than men. Patients who
reported good or very good health waited approximately
three months less than those with poor health. Finally,
patients who had visited their GP more than five times
during the past 12 months reduced their waiting time of
almost three months compared to those with fewer
visits.
In model 2 (non-logged dependent variable) the
choice and mobility variables were included. There were
small changes in the effects of the socio-demographic
and variables describing health status. The estimates of
the fixed-effect variables also remained stable. The
dummy variables describing choice and mobility (where
non-choice and non-mobile patients are the reference
category) showed the expected pattern. Patients belong-
ing to the reference category faced the longest waiting
time. On average, they waited seven weeks longer than
patients who themselves had chosen the local hospital.
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Those who had not chosen but had still moved waited
almost nine and a half weeks less than the reference
group. Finally, patients who individually had chosen a
hospital and moved experienced a shorter wait of about
11 weeks relative to the reference category.
Model 3 contains the same explanatory variables as
model 2 but with a logged dependent variable to handle
the problem of skewness. The associations between the
demographic and enabling factors and waiting time
were, with the exception of education, insignificant. The
variables describing health status lost their significance.
The effects of the choice and mobility dummies were
still important to explain differences in waiting time as
patients belonging to the reference category (non-choice
and non-mobile patients) had longer waiting time than
those who has either chosen or moved. The results did
however indicate that mobility was more important in
explaining differences in waiting time than choice, as
the variable describing choice and non-mobility became
non-significant.
Model 4 (logged dependent variable) contained the
same explanatory variables as the previous two models,
but the explanatory variables describing choice and
mobility have now been instrumented. The estimates of
the demographic, enabling and need variables are similar
to those of model 3. The instrument variable describing
choice or mobility was highly significant and indicates
that choice and mobility were important predictors of
waiting time.
Table 1 Average waiting times for elective treatment according to main diagnoses groups (ICD10), 2003-2004
Chapter ICD10 chapter N Mean wts S.D
2 Neoplasm and diseases of the blood and blood-forming organs 116 374.6 531.9
4 Endocrine, nutritional and metabolic diseases 40 489.0 599.9
6 Diseases of the nervous system 122 251.4 355.0
7 Diseases of the eye and adnexa 79 264.4 389.5
8 Diseases of the ear and mastoid process 56 453.8 490.5
9 Diseases of the circulatory system 92 261.0 345.8
10 Diseases of the respiratory system 64 260.6 361.8
11 Diseases of the digestive system 79 252.5 437.8
12 Diseases of the skin and subcutaneous tissue 64 327.3 457.6
13 Diseases of the musculoskeletal system and connective tissue 248 308.4 445.5
14 Diseases of the genitourinary system 71 216.1 338.7
15 Pregnancy, childbirth and the puerperium 38 130.4 144.9
17 Congenital malformations, deformations and chromosomal abnormalities 48 587.4 573.3
18 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified 78 234.1 285.0
19 Injury, poisoning and certain other consequences of external causes 117 157.4 203.8
21 Factors influencing health status and contact with health services 270 218.7 333.6
Total 1596 278.8 405.9
Table 2 Descriptive statistics for the participants included
in the analyses*
Variable N Min Max Mean S.D
Wts-Waiting time 1674 1 1650 299 431
Log(wts) 1674 -9.21 7.40 3.86 3.90
Age 1674 0 96 46.1 22.95
Gender (female = 1) 1674 0 1 0.45 0.50
Distance to local hospital (km) 1671 2 353 31.8 46.3
Education (years after primary school) 1490 0 17 3.9 3.1
Income 1552 1 6 3.35 1.47
Health status 1604 0 1 0.62 0.49
Number of visits to GP 1601 0 1 0.37 0.48
Number of hospital stays 1518 0 1 0.35 0.48
Non-choice & non-mobile patients 1626 0 1 0.46 0.49
Choice & non-mobile patients 1626 0 1 0.20 0.40
Non-choice & mobile patients 1626 0 1 0.17 0.38
Choice & mobile patients 1626 0 1 0.13 0.34
Year of treatment (2004 = 1) 1674 0 1 0.63 0.48
Type of treatment (surgical = 1) 1674 0 1 0.23 0.42
* Weighted results.
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Table 3 Multivariate analysis of waiting times for elective care (estimates with standard error in parentheses)
Variable: Model 1 Sig. Model 2 Sig. Model 3 Sig. Model 4 Sig.
Estimate (S.E) Estimate (S.E) Estimate (S.E) Estimate (S.E)
Age -0.31 (0.63) -0.35 (0.64) -0.01 (0.01) -0.00 (0.00)
Gender 23.66 (12.54) * 24.27 (12.53) * 0.15 (0.15) 0.30 (0.13) **
Distance to local hospital -0.18 (0.26) -0.14 (0.26) 0.00 (0.00) 0.00 (0.00)
Education -5.50 (4.24) -3.74 (4.29) -0.11 (0.07) * -
Income -9.31 (9.54) -10.98 (9.55) -0.08 (0.12) -
Health status -99.07 (28.76) **** -90.19 (28.96) *** -0.51 (0.32) 0.24 (0.40)
Number of visits to GP -89.67 (27.31) **** -85.95 (27.30) *** -0.03 (0.29) 0.20 (0.31)
Number of hospital stays 0.83 (26.15) 5.59 (26.23) 0.16 (0.30) 0.52 (0.31) *
Non-choice & non-mobile - 0.00 0.00 0.00
Choice & non-mobile - -50.60 (30.12) * -0.24 (0.45) -
Non-choice & mobile - -65.80 (33.58) ** -1.29 (0.32) **** -
Choice & mobile - -78.19 (36.04) ** -0.62 (0.33) * -
IV for choice/mobility - - - -5.36 (1.46) ****
Year 2003 76.58 (24.77) *** 77.04 (24.88) *** -0.45 (0.28) -0.34 (0.27)
Year 2004 0.00 0.00 0.00 0.00
ICD10 chapter 2 307.39(51.84) **** 304.16 (51.88) **** 1.71 (0.59) *** 4.33 (1.52) ***
ICD10 chapter 4 351.46 (77.57) **** 347.25 (77.49) **** 2.26 (0.51) **** 4.92 (1.64) ****
ICD10 chapter 6 69.70 (53.65) 80.17 (53.83) -0.70 (0.77) 1.66 (1.51)
ICD10 chapter 7 106.32 (59.83) * 112.60 (59.82) * 1.02 (0.57) * 3.63 (1.55) **
ICD10 chapter 8 240.73 (71.45) **** 239.69 (71.43) **** 1.10 (1.10) 3.83 (1.61) **
ICD10 chapter 9 53.65 (52.34) 46.92 (52.38) 1.17 (0.66) * 3.80 (1.51) **
ICD10 chapter 10 104.20(63.39) 101.55 (63.30) 1.38 (0.52) *** 4.12 (1.55) ***
ICD10 chapter 11 75.02 (56.06) 67.08 (56.12) 1.70 (0.49) **** 4.32 (1.53) ****
ICD10 chapter 12 82.97 (63.19) 72.68 (63.35) 1.30 (0.58) ** 3.97 (1.57) **
ICD10 chapter 13 124.00 (39.46) *** 126.27 (39.49) *** 1.02 (0.47) ** 3.61 (1.47) **
ICD10 chapter 14 76.00 (59.14) 72.22 (59.15) 1.18 (0.51) ** 3.73 (1.54) **
ICD10 chapter 15 -21.30(68.32) -26.36 (68.40) -0.75 (1.26) 1.87 (1.60)
ICD10 chapter 17 274.38 (84.51) **** 276.53 (84.42) **** 2.28 (0.57) **** 5.10 (1.66) ****
ICD10 chapter 18 -30.48 (61.28) -33.45 (61.24) 0.49 (0.81) 3.11 (1.55) **
ICD10 chapter 19 -53.81 (54.18) -49.94 (54.16) -1.42 (0.87) 1.18 (1.51)
ICD10 chapter 21 0.00 0.00 0.00 2.61 (1.46) *
Medical treatment 83.71 (28.57) *** 73.27 (28.80) *** 0.60 (0.28) ** -
Surgical treatment 0.00 0.00 0.00 -
Estimation procedure OLS with fixed effects OLS with fixed effects OLS with fixed effects 2SLS with fixed effects
Number of observations 1274 1274 1348 1361
-2LogLikelihood 19202 19169 8048
R2 0,07
****sig. = 0.001, *** sig. = 0.01, **sig. = 0.05, *sig. = 0.10
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5. Discussion
Prolonged waiting times for elective treatment have long
been considered a serious problem of the Norwegian
health care system. Overall waiting times have, due to
both supply and demand reforms, dropped significantly
over recent years. Despite the positive development,
many patients still face substantial waiting times. The
analysis provides support for claiming that a policy of
combining patient choice of hospital with the removal
of geographical restrictions on referrals may contribute
to the reduction in waiting times for individual elective
patients. The main results of the empirical analyses
were found to be robust over different statistical model
specifications. Patients who chose to move hospitals
benefit the most. They spend about 11 weeks less, on
average, waiting for hospital treatment than those who
neither chose nor moved. The results corroborate with
the results of a few previous empirical analyses, like The
London Patient Choice Project. There, a reduction in
waiting times for all patients was found after choice was
introduced, including also for those who did not partici-
pate in the project [6].
Compared with previous analyses this study has some
methodological advantages. By combining register data
with information from a specially designed survey of
patients, it has been possible to measure empirically both
the individual patient’s hospital choice and the subse-
quent mobility/non-mobility. This has not been possible
in studies based upon register data [18]. Compared with
general population studies, the current study offers
another advantage. To study patients, and ask them
about their experiences relating to a particular treatment
episode, brings us closer to actually investigating revealed
preferences (what people do) than stated preferences
(what people say they do) [27]. Finally, our sample was
drawn in a manner that permits generalization, and tests
have been conducted to ensure that the study sample
does not diverge from the patient population on impor-
tant characteristics such as gender and factors related to
the hospital stay. The only exception is that the study
participants on average are about two year younger than
the Norwegian patient population as a whole.
The main limitation in our study is the number of
non-responders. This is, however, not a problem con-
fined to this particular study; most surveys of hospital
patients in Norway struggle to reach high response rates
[28]. Research suggests that the main reason for non-
response is that many patients still are, when invited to
participate in a survey, too sick or weak to fill in a ques-
tionnaire [29]. A selection bias can therefore not entirely
be ruled out. The study design does not allow us to
draw firm causal inferences although the instrument
variable approach comes close to that. In order to do
this an alternative study design (e.g. a pre-post design
with a control group) would have been necessary.
Finally, one methodological limitation has to be noted
for the identification strategy of the IV-approach (table
3, model 4). As reliable instruments were hard to find,
the results of the model should be interpreted with
some care.
The results of these analyses ought to make patients
and policy makers more receptive to the potential bene-
fits of hospital choices. For patients, the immediate
implication of the study is that if one chooses to bypass
the local hospital, waiting time for hospital admission
may be significantly reduced. Another interesting finding
is that even if a patient allows somebody else to decide
on his/her behalf, the waiting time will also be reduced,
given that the patient is willing to travel to an alterna-
tive hospital. This may for instance occur because the
referring physician has used their knowledge about
spare hospital capacity to the benefit of the patient.
From the patient perspective, the least beneficial option,
when it comes to waiting, is not to choose and to end
up at the local hospital. From the perspective of policy-
makers, the main implication is that the introduction of
choice and the removal of geographical boundaries
(county borders) both contribute to a reduction in wait-
ing time for patients. Another interesting result is the
negative association between health status and waiting
time. One interpretation could be that patients with bet-
ter health finds the prospect of travelling (i.e. to become
mobile) less daunting, and therefore in turn are able to
benefit from the existence of shorter waiting times else-
where. Moreover, the analyses indicate that reduced
waiting times can be achieved without jeopardizing the
aim of equal geographical and social access to hospital
care. Further insight might also be gained by looking
into the role of referring physicians in choice and mobi-
lity decisions.
6. Conclusion
There is still relatively limited empirical evidence on the
impact of patient choice (4-6; 10). One possible direc-
tion for future research could be to refine the choice/
non-choice dichotomy used here. This line of research
could benefit from integrating concepts such as “shared
decision-making” [30], and “patient involvement/partici-
pation” [31]. A second possible direction would be to
expand the analyses of choice and mobility to explore
the impact upon other health related outcomes like
quality [32].
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Technical appendix
Variable name: Waiting times
Data source: Norwegian patient register (NPR)
Description: Number of days waited by the patient
from the reception of the referral letter at the hospital
to the actual treatment
Coding: Continuous variable
Variable name: Age
Data source: Norwegian patient register (NPR)
Coding: Continuous variable
Variable name: Gender
Data source: Norwegian patient register (NPR)
Coding: 0 = Male, 1 = Female
Variable name: Distance to local hospital
Data source: Register data
Description: Number of kilometres from centre of
home municipality to the local hospital
Coding: Continuous variable
Variable name: Education
Data source: Norwegian choice and mobility survey
(the CM-survey)




Data source: Norwegian choice and mobility survey
(the CM-survey)
Description: Income in NOK
Coding: Continuous variable 1 = less than 60,000
(NOK) 6 = 500,000 or more
Variable name: Health status
Data source: Norwegian choice and mobility survey
(the CM-survey)
Description: Dummy variable
Coding: 0 = Bad/Not so good 1 = Good/Very good
Variable name: Number of visits to GP in previous 12
months
Data source: Norwegian choice and mobility survey
(the CM-survey)
Description: Dummy variable
Coding: 0 = Five or fewer visits 1 = More than five
Variable name: Number of hospital stays in previous
12 months
Data source: Norwegian choice and mobility survey
(the CM-survey)
Description: Dummy variable
Coding: 0 = Only one stay 1 = More than one stay
Variable name: Patient choice and mobility
Data source: Combined information from the CM-
survey and NPR
Description: Dummy variable
Coding: 0 = Non-choice & non-mobility
1 = Choice & non-mobility
2 = Non-choice & mobility
3 = Choice & mobility
Variable name: Year of investigation
Data source: Norwegian choice and mobility survey
Description: Dummy variable
Coding: 0 = 2003 1 = 2004
Variable name: Type of medical treatment received
Data source: Norwegian patient register (NPR)
Description: Dummy variable
Coding: 0 = Medical treatment 1 = Surgical treatment
Variable name: Main condition treated in the hospital
episode under consideration
Data source: Norwegian patient register (NPR)
Description: Dummy variable based upon ICD-10
chapters (see Table 1 for the names of the individual
chapters):
Coding: 0 = Other condition (Ch 21)
1 = Chapter 2
2 = Chapter 4
3 = Chapter 6
4 = Chapter 7
4 = Chapter 8
4 = Chapter 9
4 = Chapter 10
4 = Chapter 11
4 = Chapter 12
4 = Chapter 13
4 = Chapter 14
4 = Chapter 15
4 = Chapter 17
4 = Chapter 18
4 = Chapter 19
Additional material
Additional file 1: The questionnaire used in the patient choice and
mobility survey. Questionnaire (in Norwegian).
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